CPTx
Hendrik Dietz is a distinguished academic and entrepreneur with extensive experience in biotechnology and nanosystems. As the Founder and CEO of CPTx since November 2021, and Co-Founder of Plectonic Biotech and LogicInk, Dietz has been instrumental in advancing innovative technologies. With a strong background in research, Dietz has served as a Full Professor at the Technical University of Munich since July 2009, and previously worked as a Postdoctoral Researcher at Harvard Medical School from June 2007 to July 2009. Dietz holds a Doctor of Philosophy - PhD in Physics from the Technical University of Munich and a Master's degree in Physics from Ludwig-Maximilians-Universität München. Additionally, Dietz founded tilibit nanosystems in April 2012, further contributing to the field of nanosystems.
This person is not in any teams
This person is not in any offices
CPTx
At CPTx, we develop new treatment paradigms across unmet medical challenges, with an initial focus on infectious diseases. The flexibility and precision of CPTx's platform support multivalent drug development, which is crucial for addressing complex disease states involving multiple binding sites, such as viruses, cancer, and autoimmune diseases.